Corticosteroids + Ustekinumab Interaction
Moderateinteraction on record
Description
Used concomitantly in approximately 40-50% of CD/UC subjects; safety and efficacy not adversely affected by combination.
Source: NLP:ustekinumab
Used concomitantly in approximately 40-50% of CD/UC subjects; safety and efficacy not adversely affected by combination.
Source: NLP:ustekinumab